Burton J P, Chilcott C N, Moore C J, Speiser G, Tagg J R
BLIS Technologies, Center for Innovation, University of Otago, Dunedin, New Zealand.
J Appl Microbiol. 2006 Apr;100(4):754-64. doi: 10.1111/j.1365-2672.2006.02837.x.
To determine whether dosing with bacteriocin-producing Streptococcus salivarius following an antimicrobial mouthwash effects a change in oral malodour parameters and in the composition of the oral microbiota of subjects with halitosis.
Twenty-three subjects with halitosis undertook a 3-day regimen of chlorhexidine (CHX) mouth rinsing, followed at intervals by the use of lozenges containing either S. salivarius K12 or placebo. Assessment of the subjects' volatile sulphur compound (VSC) levels 1 week after treatment initiation showed that 85% of the K12-treated group and 30% of the placebo group had substantial (>100 ppb) reductions. The bacterial composition of the saliva was monitored by culture and PCR-denaturing gradient gel electrophoresis (PCR-DGGE). Changes in the PCR-DGGE profiles occurred in most subjects following K12 treatment. In vitro testing showed that S. salivarius K12 suppressed the growth of black-pigmented bacteria in saliva samples and also in various reference strains of bacteria implicated in halitosis.
Administration of bacteriocin-producing S. salivarius after an oral antimicrobial mouthwash reduces oral VSC levels.
The outcome of this preliminary study indicates that the replacement of bacteria implicated in halitosis by colonization with competitive bacteria such as S. salivarius K12 may provide an effective strategy to reduce the severity of halitosis.
确定在使用抗菌漱口水后给予产细菌素的唾液链球菌是否会改变口臭患者的口腔异味参数以及口腔微生物群的组成。
23名口臭患者进行了为期3天的洗必泰(CHX)漱口疗程,之后间隔使用含唾液链球菌K12或安慰剂的含片。在治疗开始1周后评估受试者的挥发性硫化合物(VSC)水平,结果显示,85%接受K12治疗的组和30%接受安慰剂治疗的组VSC水平大幅降低(>100 ppb)。通过培养和PCR-变性梯度凝胶电泳(PCR-DGGE)监测唾液中的细菌组成。在接受K12治疗后,大多数受试者的PCR-DGGE图谱发生了变化。体外试验表明,唾液链球菌K12抑制了唾液样本中以及与口臭相关的各种参考细菌菌株中黑色色素细菌的生长。
口服抗菌漱口水后给予产细菌素的唾液链球菌可降低口腔VSC水平。
这项初步研究的结果表明,用诸如唾液链球菌K12等竞争性细菌进行定植来替代与口臭相关的细菌,可能是减轻口臭严重程度的有效策略。